Adverse effects associated with influenza vaccination in patients with COPD: A randomized controlled study

Respirology

Volumn 9, Issue 4, 2004, Pages 550-556

  Wongsurakiat, Phunsup ^a   Maranetra, Khun Nanta ^a   Gulprasutdilog, Penpun ^a   Aksornint, Monchai ^a   Srilum, Wichian ^a   Ruengjam, Chairat ^a   Sated, Wichean ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Acute exacerbation; Acute respiratory illness; Adverse reactions; COPD; Dyspnoeic symptoms; Exercise capacity; Influenza vaccination; Lung function

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; INFLUENZA VACCINE; PLACEBO; TRIPLE VACCINE; VIRUS VACCINE;

ADULT; AGED; AIRWAY OBSTRUCTION; ARTICLE; BLOOD SAMPLING; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE EXACERBATION; DOUBLE BLIND PROCEDURE; DYSPNEA; EXERCISE; FEMALE; FEVER; FORCED EXPIRATORY VOLUME; HEADACHE; HUMAN; INCIDENCE; INFLAMMATION; INFLUENZA VACCINATION; LUNG DISEASE; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MYALGIA; PAIN; PARESTHESIA; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; RASH; RHINORRHEA; SIDE EFFECT; UNIVERSITY HOSPITAL; VISUAL ANALOG SCALE; WALKING; WARM FEELING;

ACUTE DISEASE; AGED; DOUBLE-BLIND METHOD; EXERCISE TOLERANCE; FEMALE; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY FUNCTION TESTS; RESPIRATORY TRACT DISEASES;

EID: 13144256700     PISSN: 13237799     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2004.00616.x     Document Type: Article

References (35)

1. Niederman M. COPD-the role of infection. Chest 1997; 112 (Suppl.): 301S-302S.
2. Seneff MG, Wagner DP, Wagner RP, Zimmerman JE, Knaus WA. Hospital and 1-year survival of patients admitted to intensive care units with acute exacerbation of chronic obstructive pulmonary disease. JAMA 1995; 274: 1852-7.
3. Carilli AD, Gohd RS, Gordon W. A virologic study of chronic bronchitis. N. Engl. J. Med. 1964; 270: 123-7.
4. Gump DW, Phillips CA, Forsyth BR, McIntosh K, Lamborn KR, Stouch WH. Role of infection in chronic bronchitis. Am. Rev. Respir. Dis. 1976; 113: 465-74.
5. Rothbarth PH, Kempen BM, Sprenger MJW. Sense and nonsense of influenza vaccination in asthma and chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 1995; 151: 1682-6.
6. Smith CB, Golden C, Klauber MR, Kanner R, Renzetti A. Interactions between viruses and bacteria in patients with chronic bronchitis. J. Infect. Dis. 1976; 134: 552-61.
7. Fainstein V, Musher DM, Cate TR. Bacterial adherence to pharyngeal cells during viral infection. J. Infect. Dis. 1980; 141: 172-6.
8. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 1995; 152: S77-S121.
9. Siafakas NM, Vermeire P, Pride NB et al. Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force. Eur. Respir. J. 1995; 8: 1398-420.
10. The COPD Guidelines Group of the Standards of Care Committee of the BTS. BTS guidelines for the management of chronic obstructive pulmonary disease. Thorax 1997; 52 (Suppl. 5): S1-S28.
11. Williams WW, Hickson MA, Kane MA, Kendal AP, Spika JS, Hinman AR. Immunization policies and vaccine coverage among adults: the risk for missed opportunities. Ann. Intern. Med. 1988; 108: 616-25.
12. Nichol KL, Lofgren RP, Gapinski J. Influenza vaccination knowledge, attitudes, and behavior among high-risk outpatients. Arch. Intern. Med. 1992; 152: 106-10.
13. Fiebach NH, Viscoli CM. Patient acceptance of influenza vaccination. Am. J. Med. 1991; 91: 393-400.
14. de Jongste JC, Degenhart HJ, Neijens HJ, Duiverman EJ, Raatgeep HC, Kerrebijn KF. Bronchial responsiveness and leucocyte reactivity after influenza vaccine in asthmatic patients. Eur. J. Respir. Dis. 1984; 65: 196-200.
15. Hassan WU, Henderson AF, Keaney NP. Influenza vaccination in asthma. Lancet 1992; 339: 194.
16. Daggett P. Influenza and asthma. Lancet 1992; 339: 367.
17. Bell TD, Chai H, Berlow B, Daniels G. Immunization with killed influenza virus in children with chronic asthma. Chest 1978; 73: 140-5.
18. Fell PJ, Watson NP, O'Donnell HF, Simmons RL, Hasell SK. Longer term effects of live influenza vaccine in patients with chronic pulmonary disease. Lancet 1977; 1: 1282-4.
19. Advisory Group on pulmonary function tests in relation to live influenza virus vaccines. A study of live influenza virus vaccine in patients with chronic bronchitis. Report to Medical Research Council's Committee on Influenza and other Respiratory Virus Vaccines. Br. J. Dis. Chest 1980; 74: 121-7.
20. Thai Thoracic Society. Thai Guidelines for the Diagnosis and Treatment of Chronic Obstructive Pulmonary Disease. Thai Thoracic Society, Bangkok, 1996.
21. Centers for Disease Control and Prevention. Prevention and control of influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm. Report 1996; 45: 1-24.
22. Eadie MB, Stott EJ, Grist NR. Virological studies in chronic bronchitis. BMJ. 1966; 2: 671-3.
23. Anthonisen NR, Manfreda J, Warren CP, Hershfield ES, Harding GK, Nelson NA. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann. Intern. Med. 1987; 106: 196-204.
24. American Thoracic Society. Standardization of Spirometry 1994 Update. Am. J. Respir. Crit. Care Med. 1995; 152: 1107-36.
25. Stark RD, Gambles SA. A new system for assessing the effects of drugs on breathlessness. J. Clin. Respir. Physiol. 1980; 16: 244-7.
26. Butland RJ, Pang J, Gross ER, Woodcock AA, Geddes DM. Two-, six-, and 12-minute walking tests in respiratory disease. Br. Med. J. 1982; 284: 1607-8.
27. Margolis KL, Nichol KL, Poland GA, Pluhar RE. Frequency of adverse reactions to influenza vaccine in the elderly. JAMA 1990; 264: 1139-41.
28. Govaert TM, Dinant GJ, Aretz K, Masurel N, Sprenger MJ, Knottnerus JA. Adverse reactions to influenza vaccine in elderly people: randomised double blind placebo controlled trial. BMJ. 1993; 307: 988-90.
29. Margolis KL, Poland GA, Nichol KL et al. Frequency of adverse reactions after influenza vaccination. Am. J. Med. 1990; 88: 27-30.
30. Nichol KL, Margolis KL, Lind A et al. Side effects associated with influenza vaccination in healthy working adults: a randomized, placebo-controlled trial. Arch. Intern. Med. 1996; 156: 1546-50.
31. Scheifele DW, Bjornson G, Johnston J. Evaluation of adverse events after influenza vaccination in hospital personnel. CMAJ 1990; 142: 127-30.
32. Howells CHL, Tyler LE. Prophylactic use of influenza vaccine in patients with chronic bronchitis. Lancet 1961; 2: 1428-32.
33. Wolkove N, Dajczman E, Colacone A, Kreisman H. The relationship between pulmonary function and dyspnea in obstructive lung disease. Chest 1989; 96: 1247-51.
34. Hay JG, Stone P, Carter J et al. Bronchodilator reversibility, exercise performance and breathlessness in stable chronic obstructive pulmonary disease. Eur. Respir. J. 1992; 5: 659-64.
35. Carlson DJ, Ries AL, Kaplan RM. Prediction of maximum exercise tolerance in patients with COPD. Chest 1991; 100: 307-11.